NCT01633697

Brief Summary

The investigators hypothesize that education will improve exercise capacity, symptoms and quality of life in patients with chronic obstructive pulmonary disease (COPD). In addition, the investigators are interested in determining how education might alter various chemicals in the blood and exhaled breath that reflect inflammation in the lungs and the body as a whole. The investigators plan to enroll 42 patients into this study, with half of them participating at each of the two sites, Vermont Lung Center at the University of Vermont in Burlington, Vermont, and at Baylor College of Medicine in Houston, Texas. Participants will undergo a series of measurements and tests at the beginning of the study, receive formal education about COPD over the next 2 weeks, return at 6 weeks for a brief refresher session, and finally return after 12 weeks for repeat measurement and testing as was done at the beginning. Participants will be asked to keep a diary of symptoms, medication, and exercise during the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 4, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 4, 2020

Status Verified

November 1, 2020

Enrollment Period

3.2 years

First QC Date

June 29, 2012

Last Update Submit

November 2, 2020

Conditions

Keywords

emphysemachronic bronchitis

Outcome Measures

Primary Outcomes (1)

  • Exercise tolerance

    Exercise tolerance will be measured by 6 min walk distance at baseline and again after 12 weeks of the intervention

    12 weeks

Secondary Outcomes (6)

  • Dynamic hyperinflation

    12 weeks

  • Oxidative stress

    12 weeks

  • Systemic inflammation

    12 weeks

  • Lung mechanics

    12 weeks

  • Dyspnea

    12 weeks

  • +1 more secondary outcomes

Study Arms (2)

Education-Pranayama

EXPERIMENTAL

Subjects will receive education about COPD with special attention to breathing techniques

Behavioral: Pranayama

Education-Control

SHAM COMPARATOR

Subjects will receive education alone about COPD.

Behavioral: Education alone

Interventions

PranayamaBEHAVIORAL

Specific yoga-related breathing method.

Also known as: Dirgha 3-Part Breathing method
Education-Pranayama
Education aloneBEHAVIORAL

No special attention to breathing

Education-Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women, aged 18 and older, with a physician diagnosis of COPD
  • COPD defined according to GOLD criteria, with FEV1/FVC \< 0.7, and FEV1 \< 80% predicted.
  • Current non-smoker
  • Stable medical regimen for COPD over last 4 weeks
  • Stable physical activity over the last 4 weeks, with no plans for any change during the duration of the study
  • MRC Dyspnea Scale \> 2
  • Not planning to engage in any formal pulmonary rehabilitation program during the time of the study
  • No use of any nutritional supplements other than standard multivitamins

You may not qualify if:

  • Exacerbation of disease within previous 2 weeks
  • Concomitant other respiratory disease or significant cardiovascular disease
  • Previous practice of yoga
  • Current use of antioxidant supplements (e.g., vitamin C, vitamin E, n-acetylcysteine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Vermont Lung Center

Colchester, Vermont, 05446, United States

Location

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveEmphysemaBronchitis, Chronic

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchitisRespiratory Tract InfectionsInfectionsBronchial Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • David Kaminsky, MD

    University of Vermont

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

June 29, 2012

First Posted

July 4, 2012

Study Start

September 1, 2012

Primary Completion

November 1, 2015

Study Completion

October 1, 2016

Last Updated

November 4, 2020

Record last verified: 2020-11

Locations